337 related articles for article (PubMed ID: 11313951)
1. Negative regulation of bcl-2 expression by p53 in hematopoietic cells.
Wu Y; Mehew JW; Heckman CA; Arcinas M; Boxer LM
Oncogene; 2001 Jan; 20(2):240-51. PubMed ID: 11313951
[TBL] [Abstract][Full Text] [Related]
2. p53-dependent repression of the human MCL-1 gene encoding an anti-apoptotic member of the BCL-2 family: the role of Sp1 and of basic transcription factor binding sites in the MCL-1 promoter.
Pietrzak M; Puzianowska-Kuznicka M
Biol Chem; 2008 Apr; 389(4):383-93. PubMed ID: 18208354
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM
Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983
[TBL] [Abstract][Full Text] [Related]
4. In vivo complex formation of PU.1 with HDAC1 associated with PU.1-mediated transcriptional repression.
Kihara-Negishi F; Yamamoto H; Suzuki M; Yamada T; Sakurai T; Tamura T; Oikawa T
Oncogene; 2001 Sep; 20(42):6039-47. PubMed ID: 11593411
[TBL] [Abstract][Full Text] [Related]
5. TATA-less promoters of some Ets-family genes are efficiently repressed by wild-type p53.
Iotsova V; Crépieux P; Montpellier C; Laudet V; Stehelin D
Oncogene; 1996 Dec; 13(11):2331-7. PubMed ID: 8957074
[TBL] [Abstract][Full Text] [Related]
6. Induction of PIG3 and NOXA through acetylation of p53 at 320 and 373 lysine residues as a mechanism for apoptotic cell death by histone deacetylase inhibitors.
Terui T; Murakami K; Takimoto R; Takahashi M; Takada K; Murakami T; Minami S; Matsunaga T; Takayama T; Kato J; Niitsu Y
Cancer Res; 2003 Dec; 63(24):8948-54. PubMed ID: 14695212
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress regulates IGF1R expression in vascular smooth-muscle cells via p53 and HDAC recruitment.
Kavurma MM; Figg N; Bennett MR; Mercer J; Khachigian LM; Littlewood TD
Biochem J; 2007 Oct; 407(1):79-87. PubMed ID: 17600529
[TBL] [Abstract][Full Text] [Related]
8. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
[TBL] [Abstract][Full Text] [Related]
9. The zinc finger repressor, ZBP-89, recruits histone deacetylase 1 to repress vimentin gene expression.
Wu Y; Zhang X; Salmon M; Zehner ZE
Genes Cells; 2007 Aug; 12(8):905-18. PubMed ID: 17663720
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitor, Trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells.
Li H; Wu X
Biochem Biophys Res Commun; 2004 Nov; 324(2):860-7. PubMed ID: 15474507
[TBL] [Abstract][Full Text] [Related]
11. ING1 represses transcription by direct DNA binding and through effects on p53.
Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
[TBL] [Abstract][Full Text] [Related]
12. Acetylation inactivates the transcriptional repressor BCL6.
Bereshchenko OR; Gu W; Dalla-Favera R
Nat Genet; 2002 Dec; 32(4):606-13. PubMed ID: 12402037
[TBL] [Abstract][Full Text] [Related]
13. Cytoplasmic mutant p53 increases Bcl-2 expression in estrogen receptor-positive breast cancer cells.
Pratt MA; White D; Kushwaha N; Tibbo E; Niu MY
Apoptosis; 2007 Apr; 12(4):657-69. PubMed ID: 17252199
[TBL] [Abstract][Full Text] [Related]
14. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.
Phan RT; Dalla-Favera R
Nature; 2004 Dec; 432(7017):635-9. PubMed ID: 15577913
[TBL] [Abstract][Full Text] [Related]
15. Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription.
Kanaya T; Kyo S; Hamada K; Takakura M; Kitagawa Y; Harada H; Inoue M
Clin Cancer Res; 2000 Apr; 6(4):1239-47. PubMed ID: 10778946
[TBL] [Abstract][Full Text] [Related]
16. TEL contacts multiple co-repressors and specifically associates with histone deacetylase-3.
Wang L; Hiebert SW
Oncogene; 2001 Jun; 20(28):3716-25. PubMed ID: 11439334
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase activity in conjunction with E2F-1 and p53 regulates Apaf-1 expression in 661W cells and the retina.
Wallace DM; Cotter TG
J Neurosci Res; 2009 Mar; 87(4):887-905. PubMed ID: 18951482
[TBL] [Abstract][Full Text] [Related]
18. MBP-1 physically associates with histone deacetylase for transcriptional repression.
Ghosh AK; Steele R; Ray RB
Biochem Biophys Res Commun; 1999 Jul; 260(2):405-9. PubMed ID: 10403782
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding.
Hu J; Colburn NH
Mol Cancer Res; 2005 Feb; 3(2):100-9. PubMed ID: 15755876
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of histone deacetylase inhibitors on phorbol ester- and TGF-beta1 induced murine tissue inhibitor of metalloproteinases-1 gene expression.
Young DA; Billingham O; Sampieri CL; Edwards DR; Clark IM
FEBS J; 2005 Apr; 272(8):1912-26. PubMed ID: 15819885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]